ATROPEN Drug Patent Profile
✉ Email this page to a colleague
When do Atropen patents expire, and what generic alternatives are available?
Atropen is a drug marketed by MMT and is included in one NDA.
The generic ingredient in ATROPEN is atropine. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine profile page.
Summary for ATROPEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 59 |
Clinical Trials: | 3 |
Patent Applications: | 3,664 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ATROPEN at DailyMed |
Recent Clinical Trials for ATROPEN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Manitoba | Phase 4 |
Craig J. Huang | N/A |
University of Pittsburgh | Phase 1 |
Pharmacology for ATROPEN
Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for ATROPEN
US Patents and Regulatory Information for ATROPEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-004 | Sep 17, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mmt | ATROPEN | atropine | SOLUTION;INTRAMUSCULAR | 017106-003 | Jun 19, 2003 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |